We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CHHE market cap is 21.3M. The company's latest EPS is USD -0.0062 and P/E is -51.61.
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 9.28M | 9.93M | 6.49M | 0 | 112k |
| Operating Income | 4.56M | 4.89M | 1.87M | -1.65M | -1.84M |
| Net Income | 3.31M | 3.55M | 1.29M | -354k | -408k |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 45.76M | 48.24M | 53.89M | 50.75M | 45.08M |
| Total Liabilities | 8.57M | 8.57M | 9.11M | 7.95M | 5.97M |
| Total Equity | 37.18M | 39.67M | 44.78M | 42.8M | 39.11M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 5.12M | 2.4M | 5.56M | 2.12M | -42.27M |
| Investing | -124k | -152k | -13k | N/A | N/A |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 21.3M |
| Price to Earnings Ratio | -51.61 |
| Price to Sales Ratio | 188.24 |
| Price to Cash Ratio | 457.14 |
| Price to Book Ratio | 0.54 |
| Dividend Yield | - |
| Shares Outstanding | 65.54M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 4.84k |
| 52 Week Change | -43.97% |
| 52 Week High | 2.96 |
| 52 Week Low | 0.1676 |
| Spread (Intraday) | 0.63 (69.44%) |
| Company Name | China Health Industries Holdings Inc (QB) |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.chinahealthindustries.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
